Stock Market Live Updates: Sensex Lowest Level Since June 2024, Nifty Struggles At 22,100; All Indices In Red

The Sensex experienced a significant downturn, plummeting by 1,360 points, while the Nifty fell below the 22,150 mark. Among the biggest losers in this market rout were prominent names such as IndusInd Bank, Tech Mahindra, and Titan. This decline was not isolated, as both the BSE Midcap and Smallcap indices also suffered notable losses, dropping 2.6 percent and 3 percent, respectively. The sell-off was broad-based, affecting all sectoral indices, with the technology, automotive, media, and telecommunications sectors amongst the hardest hit, each declining by 2 to 4 percent.

In a comprehensive market downturn, every sectoral index found itself in negative territory. The decline was particularly steep in some of the market's key sectors. Information technology, automotive, media, and telecommunications sectors saw their value erode by 2 to 4 percent. This widespread selling pressure underscored the market's bearish sentiment, affecting a wide range of industries and leading to significant drops in market indices.

The broader market, too, was not spared in this downward spiral. The Midcap and Smallcap segments of the BSE registered declines of 2.6 percent and 3 percent, respectively, pointing to a pervasive sense of negativity among investors. This bearish trend across different market segments highlights the extensive nature of the sell-off, affecting not just the heavyweight stocks but also the broader market encompassing smaller and mid-sized companies.

LIVE Feed

Feb 28, 2025, 3:08 pm IST

Stock Live Updates: Defence Stock Bags Huge Order

Solar Industries share price dropped over 2% despite bagging huge order. The company won orders worth Rs 2,150 crore for supplying defence products. Orders awarded by international entity, and is expected to be delivered over a period of 6 years.

Feb 28, 2025, 1:38 pm IST

IREDA Shares Fall 51% from Their Peak

Indian Renewable Energy Development Agency (IREDA) witnessed a significant drop in its share price, plunging over 8 percent during intra-day trading. This downturn was notably marked as the company's shares began their journey in the Futures & Options (F&O) segment, coinciding with the commencement of the March series. This recent fall adds to a 4 percent decrease experienced in the previous session, culminating in a 25 percent reduction in February alone. This marks the most substantial monthly decline for the stock since its listing in December 2023. Despite facing a challenging month with a 25 percent dip in February, IREDA has managed to register an 11.5 percent growth over the last year. This resilience is highlighted by the company's strong performance in the third quarter, where it reported a 27 percent increase in net profit. Such financial successes have come amidst a backdrop of a significant decrease in the stock's value, over 51 percent from its peak, signaling a volatile period for the company in the stock market.

Feb 28, 2025, 12:51 pm IST

Sanofi India's 6% Share Price Jump After Q4 Success!

Sanofi India's stock saw an uptick of up to 6% in the morning trading session. The pharmaceutical giant also declared a significant dividend of ₹117 for each share, which has a face value of ₹10. This announcement came alongside the company's financial performance update, which likely contributed to the positive movement in its share price. Sanofi India's financial performance for the fourth quarter ended December 2024 was notably strong, with a profit from continuing operations soaring by 31% to ₹91.3 crore from ₹69.7 crore in the corresponding quarter of the previous year. This growth in profit is impressive, considering the company operates on a January-December financial year, making October-December its fiscal fourth quarter. The revenue from operations also saw a commendable rise, increasing by nearly 10% to ₹515 crore from ₹469 crore year-on-year. The company's share price opened at ₹5001.40 on the Bombay Stock Exchange (BSE) on Friday, marking a slight increase from Thursday's closing price of ₹4996.75. During the day, the share price peaked at ₹5317.75, registering gains of more than 6% in morning trades. However, despite this positive momentum, Sanofi India's shares relinquished most of their gains as the broader stock market faced a downturn, with the Sensex dropping almost 1000 points.

Feb 28, 2025, 11:53 am IST

Zen Technologies Secures Patent for Automated Hard Kill Firearm Mounting System

Zen Technologies Limited proudly announces that it has secured a Patent Grant for its Automated Hard Kill Firearm Mounting System. This cutting-edge innovative system is designed to enhance defence capabilities through autonomous target detection and engagement, significantly reducing response times and improving operational efficiency in combat scenarios. The Hard Kill Firearm Mounting System, filed on 15th October 2022, is now patented up to 15th October 2042 under the Indian Patents Act. This latest grant marks Zen Technologies third patent in calendar year 2025 and the 13th in FY 2024-25, reinforcing the company’s strong commitment to developing indigenous defence solutions.

Feb 28, 2025, 11:41 am IST

TCS Extends Partnership with DNB Bank ASA by 5 Years to Power Next-Gen Banking Innovation

Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a leading global IT services, consulting, and business solutions company, has extended its partnership with DNB Bank ASA, Norway’s largest financial services group, for an additional five years. This extension builds on a longstanding and successful collaboration, paving the way for continued growth and innovation. Under the renewed partnership, TCS will continue as DNB's strategic partner, supporting the bank’s digital modernization journey while enhancing cost efficiency targets. In addition, TCS will deploy next-generation technology for DNB’s modernization initiatives by maintaining and developing new applications, strengthening security capabilities, and providing insights on next-generation technologies, including AI and quantum computing.

Feb 28, 2025, 11:39 am IST

Ola Electric sells 25,000 Units during February 2025

Ola Electric, India’s largest pure-play EV company, today announced its sales for the month of February 2025. Backed by a strong S1 portfolio and sales-and-service network of 4,000 stores across the country, the company sold more than 25,000 units in February with a market share of over 28%, cementing its market leadership in the EV 2W segment.

Feb 28, 2025, 10:46 am IST

Biocon Limited launches its Glucagon-like peptide-1 (GLP -1), Liraglutide,

Biocon Limited, an innovation-led global biopharmaceutical company, today announced the launch of its GLP-1 peptide, Liraglutide, for diabetes and obesity, in the United Kingdom (U.K.). The drug-device combination will be marketed in the U.K. under the brand names Liraglutide Biocon for diabetes (gVictoza®) and Biolide for chronic weight management (gSaxenda®). The launch follows the approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K., earlier this year, making Biocon Limited the first generics company to obtain approval for gLiraglutide in a major regulated market.

Feb 28, 2025, 9:57 am IST

Expiry Fails To Trigger A Breakout – Nifty Awaits Direction Near 22,500-22,950

“Parallel consolidation continued yesterday as well, with expiry surprisingly failing to trigger break out moves. Oscillators do show positive divergence, supporting upswing theories, potentially aiming for the 22620-730 region initially. But as maintained all this week, we will wait for 22950 to be conquered, as a confirmation of strength. Downside markers can continue to be in the 22500 vicinity, while deeper support is seen at 22300,” said Anand James, Chief Market Strategist, Geojit Financial Services.

Feb 28, 2025, 9:38 am IST

Opening Bell

Amidst the full-blown trade war between the United States and China, the Indian stock market saw a bloodbath during Friday's opening trading. At 22,322, the Nifty was down 224 points, while the Sensex was down 744 points at 73,868.

Feb 28, 2025, 9:25 am IST

Stock Market Outlook Today By Dr. V K Vijayakumar, Chief Investment Strategist, Geojit Financial Services

Stock markets dislike uncertainty, and uncertainty has been on the rise ever since Trump was elected the US president. The spate of tariff announcements by Trump has been impacting markets and the latest announcement of additional 10% tariff on China is a confirmation of the market view that Trump will use the initial months of his presidency to threaten countries with tariffs and then negotiate for a settlement favourable to the US. How China responds to the latest round of tariffs remains to be seen. Even now the markets have not discounted a full blown trade war between the US and China. It is likely to be avoided. However, the uncertainty element has increased as reflected in the sharp spike in CBOE volatility index to 21.13. March is likely to witness recovery in the Indian market backed by better macro news flows and subdued FII selling. Since largecap valuations are fair, and in pockets attractive, FIIs are unlikely to press selling as aggressively during the last few months. Long-term investors can utilise the weakness in the market to slowly accumulate fairly-valued quality largecaps and select fairly-valued stocks in the broader market, like defence stocks for instance.

Feb 28, 2025, 9:08 am IST

Rupee Vs Dollar

The Indian rupee began lower on Friday at 87.31 per dollar compared to its previous closing price of 87.19.

Feb 28, 2025, 8:50 am IST

Tata Power Shares In Focus Today

The Solar Energy Corporation of India Limited (SECI) on Thursday awarded TP Solar Limited (TP Solar), a wholly owned subsidiary of Tata Power Renewable Energy Limited (TPREL) and a subsidiary of Tata Power, a contract worth Rs 632 crore for the supply of 292.5 MWp DCR (Domestic Content Requirement) Solar Modules.

Feb 28, 2025, 8:47 am IST

RVNL Shares In Focus

In order to meet the 3000 MT loading target on EPC mode, Central Railway has given Rail Vikas Nigam Limited a work order worth Rs 135,66,41,737.92 for the commissioning of 132/55 KV Traction Substation, Sectioning post (SPs) and Sub sectioning post (SSPs) in 2 x 25 KV Traction System (Scott Connected Transformer) of Bhusaval-Khandwa Sections of Central Railway.

Feb 28, 2025, 8:36 am IST

Nifty Bank Prediction By Om Mehra, Technical Analyst, SAMCO Securities

The broader trend continues to exhibit a pattern of lower highs and lower lows, indicating underlying weakness. The 9 EMA, currently positioned at 49,100, acts as immediate resistance, capping any upside attempts. On the downside, support stands at 48,280, and a breach of this level could accelerate the decline toward 48,000. Meanwhile, the MACD remains skewed to the downside, and the ongoing mean reversion lacks additional confirmation. This phase of consolidation and uncertainty may extend over the next few sessions.

Feb 28, 2025, 8:36 am IST

Nifty Prediction By Om Mehra, Technical Analyst, SAMCO Securities

On the daily chart, a Doji formation highlights indecisiveness. Nifty would remain directionless until a decisive breakout occurs beyond the 22,500–22,700 range. Meanwhile, the daily RSI has slipped below 30, entering oversold territory. A breakdown below 22,500 could accelerate the decline toward 22,350, followed by 22,270. However, this appears to be more of a time than a price correction. In such conditions, attempting to catch the bottom may prove premature unless a reversal is confirmed with additional confluence.

Feb 28, 2025, 8:26 am IST

Nifty Bank Options Market Insights By Dhupesh Dhameja, Derivatives Analyst, SAMCO Securities

Derivatives data continues to favour a bearish stance, with call writers maintaining a firm grip over put sellers, indicating a cautious sentiment. A surge in open interest at the 49,000-strike call (9.70 lakh contracts) solidifies this level as a strong resistance, while substantial put writing at the 48,000 strike (6.34 lakh contracts) suggests that buyers are actively defending lower levels. The 49,000–49,500 zone remains under intense call writing pressure, reinforcing overhead resistance, while increasing put activity at lower strikes points to a tug-of-war between bulls and bears, reflecting market uncertainty. The Put-Call Ratio (PCR) climbed to 0.83 from 0.78, indicating a marginal increase in bullish attempts, yet sellers continue to hold dominance. Meanwhile, the ‘Max Pain’ level at 48,900 hints that any sharp decline could attract buyers, providing short-term support unless a decisive breakdown occurs, which could trigger accelerated selling pressure.

Feb 28, 2025, 8:21 am IST

Bank Nifty Outlook By Dhupesh Dhameja, Derivatives Analyst, SAMCO Securities

The index remained confined within the prior trading range, forming an upper wick and a narrow body, making yesterday’s high and low crucial markers for the next move. Sustained selling pressure highlights underlying weakness, while repeated failures to sustain above resistance levels cast doubts on trend stability. The 48,300 mark now serves as the final foothold for bulls to attempt a mean-reversion bounce, while the 48,900-49,000 zone, which coincides with the short-term moving average, has transformed into a formidable resistance, reinforced by aggressive call writing. A clear breakout from the ongoing range will dictate the index’s directional trajectory in the upcoming sessions.

Feb 28, 2025, 8:06 am IST

Nifty Options Market Insights By Dhupesh Dhameja, Derivatives Analyst, SAMCO Securities

Derivative trends maintain a bearish bias, with call writers continuing to overpower put sellers, signalling a defensive stance. A substantial open interest accumulation at the 23,000-strike call (54.86 lakh contracts) cements it as a formidable resistance zone, while significant put accumulation at the 22,500-strike (50.54 lakh contracts) establishes a solid base at lower levels. The 22,600–23,000 range remains under heavy call writing pressure, whereas rising put activity at lower strikes signals an ongoing tug-of-war between bulls and bears, highlighting market fragility. The Put-Call Ratio (PCR) climbed to 0.78 from 0.63, hinting at a marginally improving sentiment, but sellers remain in control despite sporadic buying attempts. Meanwhile, the ‘Max Pain’ level at 22,600 suggests that while volatility persists, buyers may attempt to cushion declines in the short term.

Feb 28, 2025, 8:06 am IST

Nifty Outlook Today By Dhupesh Dhameja, Derivatives Analyst, SAMCO Securities

The index continues to oscillate within its previous trading range, forming a Doji candle, making previous day’s high and low the key reference points for upcoming price action. Persistent downward pressure underscores market weakness, while the failure to sustain gains at resistance levels raises concerns about trend stability. The 22,500 level remains the bulls’ final defensive stronghold, while the 22,700-mark, last week’s low has transformed into a firm resistance, reinforced by aggressive call writing. A decisive breakout from this range will dictate the market’s next directional move.